Overview
CRVO market data
Price History
CRVO price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.98 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.60 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.35 – $13.13 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $31.9 · P/B 4.01 · P/S 15.25.
Company news
HC Wainwright & Co. Reiterates Buy on CervoMed, Maintains $25 Price TargetBenzinga · Jul 15, 2026, 10:40 AM
8-K filing — CervoMed Inc. (CRVO)SEC EDGAR · Jul 14, 2026, 8:21 PM
CervoMed Presents New Insights Into Neflamapimod's Treatment Effects In Dementia with Lewy Bodies At The Alzheimer's Association International Conference 2026Benzinga · Jul 14, 2026, 11:55 AM
CervoMed Completes Enrollment In Phase 2A Study Of Neflamapimod For nfvPPA, Type Of Frontotemporal Dementia; First Biomarker Data Expected In Early Q4 Of 2026 And The First Clinical Data In Q1 2027Benzinga · Jul 9, 2026, 11:40 AM
CervoMed Files Prospectus Related To Offer And Resale Of 10.08M Shares Of Common Stock By Selling StockholdersBenzinga · Jul 6, 2026, 9:10 PM
CervoMed Shares Halted On Circuit Breaker To The Downside, Stock Now Up 5.77%Benzinga · Jun 18, 2026, 5:20 PM
CervoMed Shares Halted On Circuit Breaker To The Downside, Stock Now Up 42.52%Benzinga · Jun 18, 2026, 4:50 PM
CervoMed Announces $10M Registered Direct Offering Of 2.5M Shares At $4/Share To Fund Working Capital And General Corporate PurposesBenzinga · Jun 18, 2026, 4:40 PM
CervoMed Shares Halted On Circuit Breaker To The Downside, Stock Now Up 72.18%Benzinga · Jun 18, 2026, 4:40 PM
CervoMed Receives U.S. Patent For Its Neflamapimod Drug Candidate For The Treatment Of Dementia With Lewy BodiesBenzinga · Jun 18, 2026, 11:10 AM